EUVIMEDEUVIMED entdecken
CrossrefInfokarte

A 4-Domain Composite PCMR Score for Risk Stratification in Community-Acquired Pneumonia: A Single-Center Pilot Study

Mete Tuğcan Ucdal, Güliz Evik, Melike Elif Celik, Saniye Beyza Kuru, Ebru Aykan Mavigoz

The European Research Journal · 2026-11-10 · 1-12

DOI: 10.18621/eurj.1370 ↗
AbstractBibliografische Angaben

Abstract

Objective: Established community-acquired pneumonia (CAP) severity scores, such as CURB-65, rely on physiological derangement. We explored whether an admission score combining inflammatory, metabolic, nutritional, and radiographic data could stratify risk. Methods: We retrospectively analyzed 74 of 96 adults hospitalized with CAP at a Turkish state hospital between January 2024 and June 2025. The PCMR score assigns 1 point each for neutrophil-to-lymphocyte ratio ≥7.85, triglyceride-glucose index ≥8.89, Geriatric Nutritional Risk Index ≤92, and multilobar infiltrate. The laboratory cutoffs were derived via Youden index within this cohort. The primary outcome was intensive care admission, invasive mechanical ventilation, or in-hospital death. Comparators included CURB-65, complete SMART-COP, and Pneumonia Severity Index class. Internal validation used repeated cross-validation and bootstrapping. Results: The outcome occurred in 10 of 74 patients (13.5%), all requiring intensive care. The apparent area under the receiver operating characteristic curve (AUC) of the PCMR score was 0.90 (95% CI, 0.81–0.97), decreasing to 0.86 after bootstrap optimism correction and 0.81 in cross-validation. The apparent AUC was 0.92 for SMART-COP, 0.90 for Pneumonia Severity Index, 0.81 for CURB-65, and 0.77 for neutrophil-to-lymphocyte ratio alone. No paired difference was statistically significant. No patient scoring 0 or 1 experienced an event. Conclusions: In this pilot cohort, the PCMR score showed good apparent discrimination, which decreased after internal validation and was not superior to SMART-COP or Pneumonia Severity Index. This 4-domain concept requires prospective validation with fixed cutoffs in larger cohorts before clinical use.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →